Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
---|---|---|---|---|
12q13.11 | ?Epiphyseal dysplasia, multiple, with myopia and deafness | 132450 | AD | 3 |
?Vitreoretinopathy with phalangeal epiphyseal dysplasia | 619248 | AD | 3 | |
Achondrogenesis, type II or hypochondrogenesis | 200610 | AD | 3 | |
Avascular necrosis of the femoral head | 608805 | AD | 3 | |
Czech dysplasia | 609162 | AD | 3 | |
Kniest dysplasia | 156550 | AD | 3 | |
Legg-Calve-Perthes disease | 150600 | AD | 3 | |
Osteoarthritis with mild chondrodysplasia | 604864 | AD | 3 | |
Platyspondylic skeletal dysplasia, Torrance type | 151210 | AD | 3 | |
SED congenita | 183900 | AD | 3 | |
SMED Strudwick type | 184250 | AD | 3 | |
Spondyloepiphyseal dysplasia, Stanescu type | 616583 | AD | 3 | |
Spondylometaphyseal dysplasia, Algerian type | 184253 | AD | 3 | |
Spondyloperipheral dysplasia | 271700 | AD | 3 | |
Stickler syndrome, type I | 108300 | AD | 3 | |
Stickler syndrome, type I, nonsyndromic ocular | 609508 | AD | 3 |
|
|
|
|
|
|
Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
---|---|---|---|---|
2q35 | Glomerulopathy with fibronectin deposits 2 | 601894 | AD | 3 |
Spondylometaphyseal dysplasia, corner fracture type | 184255 | AD | 3 |
|
|
|
|
|
|
Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
Gene/Locus |
Gene/Locus MIM number |
---|---|---|---|---|---|---|
2q35 | Spondylometaphyseal dysplasia, corner fracture type | 184255 | AD | 3 | FN1 | 135600 |
|
|
|
|
Dear OMIM User,
To ensure long-term funding for the OMIM project, we have diversified our revenue stream. We are determined to keep this website freely accessible. Unfortunately, it is not free to produce. Expert curators review the literature and organize it to facilitate your work. Over 90% of the OMIM's operating expenses go to salary support for MD and PhD science writers and biocurators. Please join your colleagues by making a donation now and again in the future. Donations are an important component of our efforts to ensure long-term funding to provide you the information that you need at your fingertips.
Thank you in advance for your generous support,
Ada Hamosh, MD, MPH
Scientific Director, OMIM